Perspectives Patient Education Randomized Study

Medication Adherence Clinical Trial

Official title:

Perspectives Post Percutaneous Coronary Intervention Randomized Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04439864
• Other study ID #: 2013-0802
• Secondary ID: P30AG022849UL1TR
• Status: Completed
• Phase: N/A
• Start date: May 1, 2014
• Est. completion date: February 28, 2017

Study information

• Verified date: June 2020
• Source: University of Illinois at Chicago
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a randomized clinical trial evaluating the educational program called My Interventional Drug Eluting Stent Educational App (MyIDEA) that is a pilot at two sites.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: February 28, 2017
• Est. primary completion date: February 28, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

1. received a drug eluting stent during a Percutaneous Coronary Intervention (PCI) during a hospitalization for the PCI procedure,

2. were greater than 50 years old (funding agency requirement),

3. spoke and understood English.

Exclusion Criteria:

1. inability to give informed consent

2. allergy to aspirin

Related Conditions & MeSH terms

• Medication Adherence

Intervention

Device:
• MyIDEA
An educational tablet app that is customized to the patient based on the data in the Electronic Health Record.

Locations

Country	Name	City	State
n/a

Sponsors (5)

Lead Sponsor	Collaborator
University of Illinois at Chicago	John H. Stroger Hospital, National Institute of Nursing Research (NINR), National Institute on Aging (NIA), National Institutes of Health (NIH)

References & Publications (2)

Boyd AD, Moores K, Shah V, Sadhu E, Shroff A, Groo V, Dickens C, Field J, Baumann M, Welland B, Gutowski G, Flores JD Jr, Zhao Z, Bahroos N, Hynes DM, Wilkie DJ. My Interventional Drug-Eluting Stent Educational App (MyIDEA): Patient-Centered Design Method — View Citation

Shah V, Dileep A, Dickens C, Groo V, Welland B, Field J, Baumann M, Flores JD, Shroff A, Zhao Z, Yao Y, Wilkie DJ, Boyd AD. Patient-Centered Tablet Application for Improving Medication Adherence after a Drug-Eluting Stent. Front Public Health. 2016 Dec 12;4:272. doi: 10.3389/fpubh.2016.00272. eCollection 2016. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility of study design engaging elderly patients in novel tablet based education.	Would research participants enroll and follow up in a study of tablet based education. Do patients think they know everything? Would patients enrolled in the control arm still follow up in the study?	3 months
Secondary	Medication adherence	A measure of Pharmacy days covered for DAPT medication. The patients after recieving a Drug Eluting Stent need to adhere to Dual Antiplatlet Therapy (DAPT) to prevent restenosis of the stent. PDC is a calculation of the DAPT which is Aspirin and an ADP receptor antagonist. As aspirin is over the counter, the pharmacy does not have a record of purchase so the PDC was calculated for the ADP receptor antagonis.	3 months